Filing Details
- Accession Number:
- 0001181431-11-011247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-17 20:00:27
- Reporting Period:
- 2011-02-15
- Filing Date:
- 2011-02-17
- Accepted Time:
- 2011-02-17 20:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1486428 | William Slichenmyer | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-15 | 6,000 | $0.00 | 6,000 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2011-02-16 | 2,000 | $9.64 | 8,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-16 | 2,000 | $14.26 | 6,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-02-17 | 1,000 | $9.64 | 7,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-17 | 1,000 | $16.00 | 6,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2011-02-15 | 12,500 | $0.00 | 12,500 | $12.24 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2011-02-15 | 17,500 | $0.00 | 17,500 | $14.16 |
| Common Stock | Stock Option (right to buy) | Disposition | 2011-02-16 | 2,000 | $0.00 | 2,000 | $9.64 |
| Common Stock | Stock Option (right to buy) | Disposition | 2011-02-17 | 1,000 | $0.00 | 1,000 | $9.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,500 | 2011-02-15 | 2020-12-31 | No | 4 | A | Direct |
| 17,500 | 2021-02-15 | No | 4 | A | Direct | |
| 171,500 | 2019-10-08 | No | 4 | M | Direct | |
| 170,500 | 2019-10-08 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2010.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.46 to $14.1701, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- The option vested as to 25% of the shares on September 14, 2010 and in equal monthly installments thereafter as to the remaining shares through September 14, 2013.
- On February 2, 2010, the reporting person was granted an option to purchase 12,500 shares of Issuer common stock. The option vests in two equal installments. The first installment vests based on AVEO's satisfaction of certain performance criteria for the fiscal year ended December 31, 2010. The performance criteria was met, which resulted in vesting of the option as to 50% of the shares. The second installment vests on December 31, 2011.
- This option vests in equal monthly installments from January 1, 2011 through January 1, 2015
Billionaire Hedge Funds
